Glucovance Australia - English - Department of Health (Therapeutic Goods Administration)

glucovance

alphapharm pty ltd - glibenclamide; metformin hydrochloride -

Acetazolamide 250mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

acetazolamide 250mg tablets

advanz pharma - acetazolamide - oral tablet - 250mg

METHOTREXATE Solution for Injection 50 mg/2 ml Mg/Ml Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate solution for injection 50 mg/2 ml mg/ml

cyanamid of great britain - methotrexate sodium - solution for injection - 50 mg/2 ml mg/ml

METHOTREXATE Solution for Injection 1g/40 ml Mg/Ml Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate solution for injection 1g/40 ml mg/ml

cyanamid of great britain - methotrexate sodium - solution for injection - 1g/40 ml mg/ml

Doxine New Zealand - English - Medsafe (Medicines Safety Authority)

doxine

viatris limited - doxycycline hyclate 115mg equivalent to doxycycline 100 mg;  ;  ;  ; doxycycline hyclate 115mg equivalent to doxycycline 100 mg; doxycycline hyclate 115mg equivalent to 100 mg doxycycline - film coated tablet - 100 mg - active: doxycycline hyclate 115mg equivalent to doxycycline 100 mg       excipient: carnauba wax colloidal silicon dioxide colour film coat 5511 magnesium stearate microcrystalline cellulose pregelatinised maize starch active: doxycycline hyclate 115mg equivalent to doxycycline 100 mg excipient: carnauba wax colloidal silicon dioxide diethyl phthalate ethanol hypromellose magnesium stearate microcrystalline cellulose opaspray yellow k-1f-6012b pregelatinised maize starch purified water active: doxycycline hyclate 115mg equivalent to 100 mg doxycycline excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry yellow oy-ls-32814 pregelatinised maize starch - doxycycline is indicated in the treatment of uncomplicated chest, urethral, endocervical or rectal infections in adults caused by susceptible organisms (see actions) as shown by culture and sensitivity testing. it may also be a useful adjunct to amoebicides in acute intestinal amoebiasis and has a place as adjunctive therapy in severe acne.

Epilim IV New Zealand - English - Medsafe (Medicines Safety Authority)

epilim iv

pharmacy retailing (nz) ltd t/a healthcare logistics - sodium valproate 400mg - powder for injection with diluent - 100 mg/ml - active: sodium valproate 400mg excipient: water for injection - epilim iv: the treatment of patients with epilepsy or bipolar disorder, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

Mivacron New Zealand - English - Medsafe (Medicines Safety Authority)

mivacron

pharmacy retailing (nz) ltd t/a healthcare logistics - mivacurium chloride 2.14 mg/ml equivalent to 2 mg/ml mivacurium cation - solution for injection - 2 mg/ml - active: mivacurium chloride 2.14 mg/ml equivalent to 2 mg/ml mivacurium cation excipient: hydrochloric acid water for injection - mivacron is a highly selective, short-acting, non-depolarising neuromuscular blocking agent with a fast recovery profile. mivacron is used as an adjunct to general anaesthesia to relax skeletal muscles and to facilitate tracheal intubation and mechanical ventilation.

METHOTREXATE 1g/40 ml Mg/Ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate 1g/40 ml mg/ml solution for injection

cyanamid of great britain - methotrexate sodium - solution for injection - 1g/40 ml mg/ml

METHOTREXATE 50 mg/2 ml Mg/Ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

methotrexate 50 mg/2 ml mg/ml solution for injection

cyanamid of great britain - methotrexate sodium - solution for injection - 50 mg/2 ml mg/ml

VALPRO EC500 sodium valproate 500 mg enteric coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

valpro ec500 sodium valproate 500 mg enteric coated tablet blister pack

sanofi-aventis australia pty ltd - sodium valproate, quantity: 500 mg - tablet, enteric coated - excipient ingredients: citric acid monohydrate; hypromellose; polyvinyl acetate phthalate; diethyl phthalate; purified talc; hyprolose; titanium dioxide; povidone; magnesium stearate; amaranth aluminium lake; calcium silicate; indigo carmine aluminium lake; stearic acid; macrogol 6000 - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate